Affected Systems |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
cardiovascular system
|
|
|
|
|
|
|
|
|
√
|
|
|
|
|
|
|
|
|
|
|
|
abnormal glomerular capillary morphology
|
|
|
|
|
|
|
|
|
√
|
|
|
|
|
|
|
|
|
|
|
|
cellular
|
|
|
|
|
|
|
|
|
√
|
|
|
|
|
|
|
|
|
|
|
|
increased mesangial cell number
|
|
|
|
|
|
|
|
|
√
|
|
|
|
|
|
|
|
|
|
|
|
digestive/alimentary system
|
|
√
|
|
|
|
|
|
|
|
|
|
|
√
|
|
|
|
|
N
|
|
|
digestive/alimentary phenotype
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
N
|
|
|
colitis
|
|
√
|
|
|
|
|
|
|
|
|
|
|
√
|
|
|
|
|
|
|
|
endocrine/exocrine glands
|
|
√
|
|
|
|
|
|
|
|
|
|
√
|
√
|
|
|
|
|
|
|
|
thymus hypoplasia
|
|
√
|
|
|
|
|
|
|
|
|
|
√
|
√
|
|
|
|
|
|
|
|
growth/size/body
|
|
|
√
|
√
|
√
|
√
|
|
|
|
√
|
|
|
|
|
|
|
|
|
|
|
weight loss
|
|
|
|
|
|
|
|
|
|
√
|
|
|
|
|
|
|
|
|
|
|
enlarged liver
|
|
|
√
|
|
√
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
enlarged spleen
|
|
|
√
|
√
|
√
|
√
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
hematopoietic system
|
|
√
|
√
|
√
|
√
|
√
|
√
|
√
|
√
|
√
|
|
√
|
√
|
√
|
√
|
√
|
√
|
|
N
|
√
|
hematopoietic system phenotype
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
N
|
N
|
thymus hypoplasia
|
|
√
|
|
|
|
|
|
|
|
|
|
√
|
√
|
|
|
|
|
|
|
|
enlarged spleen
|
|
|
√
|
√
|
√
|
√
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
arrested T cell differentiation
|
|
√
|
|
|
|
|
|
|
|
|
|
√
|
√
|
|
|
|
|
|
|
|
increased T cell number
|
|
|
|
|
|
|
|
|
|
|
|
|
|
√
|
|
|
|
|
|
|
decreased lymphocyte cell number
|
|
|
|
|
|
|
|
|
|
|
|
|
|
√
|
√
|
|
|
|
|
|
decreased B cell number
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
√
|
decreased plasma cell number
|
|
|
|
|
|
|
|
√
|
|
|
|
|
|
|
|
|
|
|
|
|
decreased T cell number
|
|
|
|
|
|
|
|
√
|
√
|
|
|
|
|
|
|
|
|
|
|
|
decreased double-positive T cell number
|
|
√
|
|
|
|
|
|
|
|
|
|
√
|
√
|
|
|
|
|
|
|
|
decreased CD4-positive, alpha-beta T cell number
|
|
√
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
absent CD4-positive, alpha-beta T cells
|
|
|
|
|
|
|
|
|
|
|
|
|
√
|
|
|
|
|
|
|
|
decreased CD8-positive, alpha-beta T cell number
|
|
√
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
absent CD8-positive, alpha-beta T cells
|
|
|
|
|
|
|
|
|
|
|
|
|
√
|
|
|
|
|
|
|
|
abnormal B cell morphology
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
√
|
abnormal B cell differentiation
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
√
|
abnormal transitional stage B cell morphology
|
|
|
|
|
|
|
|
√
|
√
|
|
|
|
|
|
|
|
|
|
|
|
increased B cell number
|
|
|
√
|
√
|
√
|
√
|
|
√
|
|
|
|
|
|
|
|
|
|
|
|
|
increased immature B cell number
|
|
|
|
|
|
|
|
√
|
√
|
|
|
|
|
|
|
|
|
|
|
|
increased transitional stage T2 B cell number
|
|
|
|
|
|
|
|
√
|
|
|
|
|
|
|
|
|
|
|
|
|
increased transitional stage T3 B cell number
|
|
|
|
|
|
|
|
√
|
|
|
|
|
|
|
|
|
|
|
|
|
increased mature B cell number
|
|
|
|
|
|
|
|
√
|
|
|
|
|
|
|
|
|
|
|
|
|
increased follicular B cell number
|
|
|
|
|
|
|
|
√
|
|
|
|
|
|
|
|
|
|
|
|
|
increased marginal zone B cell number
|
|
|
|
|
|
|
√
|
√
|
√
|
|
|
|
|
|
|
|
|
|
|
|
spleen hypoplasia
|
|
|
|
|
|
|
√
|
|
|
|
|
|
|
|
|
|
|
|
|
|
decreased IgA level
|
|
|
|
|
|
|
|
|
|
|
|
|
|
√
|
|
|
|
|
|
|
increased IgA level
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
√
|
|
|
|
|
|
decreased IgE level
|
|
|
|
|
|
|
|
√
|
|
|
|
|
|
|
|
√
|
|
|
|
|
decreased IgG level
|
|
|
|
|
|
|
|
√
|
√
|
|
|
|
|
|
|
|
√
|
|
|
|
decreased IgG1 level
|
|
|
|
|
|
|
|
√
|
|
|
|
|
|
|
|
|
|
|
|
|
increased IgM level
|
|
|
|
|
|
|
|
√
|
√
|
|
|
|
|
|
|
|
|
|
|
|
abnormal microglial cell physiology
|
|
|
|
|
|
|
|
|
|
√
|
|
|
|
|
|
|
|
|
|
|
immune system
|
|
√
|
√
|
√
|
√
|
√
|
√
|
√
|
√
|
√
|
N
|
√
|
√
|
√
|
√
|
√
|
√
|
N
|
|
√
|
immune system phenotype
|
|
|
|
|
|
|
|
|
N
|
|
N
|
|
|
N
|
N
|
|
N
|
N
|
|
|
colitis
|
|
√
|
|
|
|
|
|
|
|
|
|
|
√
|
|
|
|
|
|
|
|
thymus hypoplasia
|
|
√
|
|
|
|
|
|
|
|
|
|
√
|
√
|
|
|
|
|
|
|
|
enlarged spleen
|
|
|
√
|
√
|
√
|
√
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
arrested T cell differentiation
|
|
√
|
|
|
|
|
|
|
|
|
|
√
|
√
|
|
|
|
|
|
|
|
increased T cell number
|
|
|
|
|
|
|
|
|
|
|
|
|
|
√
|
|
|
|
|
|
|
decreased lymphocyte cell number
|
|
|
|
|
|
|
|
|
|
|
|
|
|
√
|
√
|
|
|
|
|
|
decreased B cell number
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
√
|
decreased plasma cell number
|
|
|
|
|
|
|
|
√
|
|
|
|
|
|
|
|
|
|
|
|
|
decreased T cell number
|
|
|
|
|
|
|
|
√
|
√
|
|
|
|
|
|
|
|
|
|
|
|
decreased double-positive T cell number
|
|
√
|
|
|
|
|
|
|
|
|
|
√
|
√
|
|
|
|
|
|
|
|
decreased CD4-positive, alpha-beta T cell number
|
|
√
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
absent CD4-positive, alpha-beta T cells
|
|
|
|
|
|
|
|
|
|
|
|
|
√
|
|
|
|
|
|
|
|
decreased CD8-positive, alpha-beta T cell number
|
|
√
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
absent CD8-positive, alpha-beta T cells
|
|
|
|
|
|
|
|
|
|
|
|
|
√
|
|
|
|
|
|
|
|
abnormal B cell morphology
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
√
|
abnormal B cell differentiation
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
√
|
abnormal transitional stage B cell morphology
|
|
|
|
|
|
|
|
√
|
√
|
|
|
|
|
|
|
|
|
|
|
|
increased B cell number
|
|
|
√
|
√
|
√
|
√
|
|
√
|
|
|
|
|
|
|
|
|
|
|
|
|
increased immature B cell number
|
|
|
|
|
|
|
|
√
|
√
|
|
|
|
|
|
|
|
|
|
|
|
increased transitional stage T2 B cell number
|
|
|
|
|
|
|
|
√
|
|
|
|
|
|
|
|
|
|
|
|
|
increased transitional stage T3 B cell number
|
|
|
|
|
|
|
|
√
|
|
|
|
|
|
|
|
|
|
|
|
|
increased mature B cell number
|
|
|
|
|
|
|
|
√
|
|
|
|
|
|
|
|
|
|
|
|
|
increased follicular B cell number
|
|
|
|
|
|
|
|
√
|
|
|
|
|
|
|
|
|
|
|
|
|
increased marginal zone B cell number
|
|
|
|
|
|
|
√
|
√
|
√
|
|
|
|
|
|
|
|
|
|
|
|
spleen hypoplasia
|
|
|
|
|
|
|
√
|
|
|
|
|
|
|
|
|
|
|
|
|
|
decreased IgA level
|
|
|
|
|
|
|
|
|
|
|
|
|
|
√
|
|
|
|
|
|
|
increased IgA level
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
√
|
|
|
|
|
|
decreased IgE level
|
|
|
|
|
|
|
|
√
|
|
|
|
|
|
|
|
√
|
|
|
|
|
decreased IgG level
|
|
|
|
|
|
|
|
√
|
√
|
|
|
|
|
|
|
|
√
|
|
|
|
decreased IgG1 level
|
|
|
|
|
|
|
|
√
|
|
|
|
|
|
|
|
|
|
|
|
|
increased IgM level
|
|
|
|
|
|
|
|
√
|
√
|
|
|
|
|
|
|
|
|
|
|
|
abnormal microglial cell physiology
|
|
|
|
|
|
|
|
|
|
√
|
|
|
|
|
|
|
|
|
|
|
decreased autoantibody level
|
|
|
|
|
|
|
|
√
|
|
|
|
|
|
|
|
|
|
|
|
|
increased autoantibody level
|
|
|
|
|
|
|
|
|
√
|
|
|
|
|
|
|
|
|
|
|
|
increased anti-chromatin antibody level
|
|
|
|
|
|
|
|
|
√
|
|
|
|
|
|
|
|
|
|
|
|
increased anti-double stranded DNA antibody level
|
|
|
|
|
|
|
√
|
|
√
|
|
|
|
|
|
|
|
|
|
|
|
increased anti-histone antibody level
|
|
|
|
|
|
|
|
|
√
|
|
|
|
|
|
|
|
|
|
|
|
skin inflammation
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
√
|
|
|
|
|
abnormal response to infection
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
√
|
|
|
|
integument
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
√
|
|
|
|
|
skin inflammation
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
√
|
|
|
|
|
abnormal dermal layer morphology
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
√
|
|
|
|
|
thick epidermis
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
√
|
|
|
|
|
liver/biliary system
|
|
|
√
|
|
√
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
enlarged liver
|
|
|
√
|
|
√
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
mortality/aging
|
|
|
√
|
√
|
√
|
√
|
|
|
|
√
|
|
|
|
|
|
|
|
|
|
|
premature death
|
|
|
√
|
√
|
√
|
√
|
|
|
|
√
|
|
|
|
|
|
|
|
|
|
|
neoplasm
|
|
|
√
|
|
√
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
increased B cell derived lymphoma incidence
|
|
|
√
|
|
√
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
increased plasmacytoma incidence
|
|
|
√
|
|
√
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
nervous system
|
|
|
|
|
|
|
|
|
|
√
|
|
|
|
|
|
|
|
|
|
|
abnormal microglial cell physiology
|
|
|
|
|
|
|
|
|
|
√
|
|
|
|
|
|
|
|
|
|
|
motor neuron degeneration
|
|
|
|
|
|
|
|
|
|
√
|
|
|
|
|
|
|
|
|
|
|
renal/urinary system
|
|
|
|
|
|
|
|
√
|
√
|
|
|
|
|
|
|
|
|
|
|
|
abnormal glomerular capillary morphology
|
|
|
|
|
|
|
|
|
√
|
|
|
|
|
|
|
|
|
|
|
|
increased mesangial cell number
|
|
|
|
|
|
|
|
|
√
|
|
|
|
|
|
|
|
|
|
|
|
renal glomerular immunoglobulin deposits
|
|
|
|
|
|
|
|
√
|
√
|
|
|
|
|
|
|
|
|
|
|
|
respiratory system
|
√
|
|
|
|
|
|
|
√
|
|
|
|
|
|
|
|
|
√
|
|
|
|
abnormal respiratory system morphology
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
√
|
|
|
|
abnormal respiratory system physiology
|
√
|
|
|
|
|
|
|
√
|
|
|
|
|
|
|
|
|
√
|
|
|
|